Abstract: Systems and methods described herein presents a PaaS level application or app motion system that manages and moves applications between multiple PaaS instances in a hybrid cloud that includes both private and public cloud instances. Specifically, the system performs an app motion operation on an application by cloning, moving, and/or scaling up the application from one PaaS instance to one or more other PaaS instances in the hybrid cloud. Since the system achieves application mobility and scalability at the PaaS level by only moving the application and its associated data between the PaaS instances without moving the virtual machines (VMs), it could greatly reduce the amount of data transmitted during the process and save both time and network resources. It also enables enterprises to extend their applications from a private cloud to a public cloud and uniformly manage the applications cross the boundaries of the clouds.

Abstract: Systems and methods described herein presents a PaaS level application or app motion system that manages and moves applications between multiple PaaS instances in a hybrid cloud that includes both private and public cloud instances. Specifically, the system performs an app motion operation on an application by cloning, moving, and/or scaling up the application from one PaaS instance to one or more other PaaS instances in the hybrid cloud. Since the system achieves application mobility and scalability at the PaaS level by only moving the application and its associated data between the PaaS instances without moving the virtual machines (VMs), it could greatly reduce the amount of data transmitted during the process and save both time and network resources. It also enables enterprises to extend their applications from a private cloud to a public cloud and uniformly manage the applications cross the boundaries of the clouds.

Abstract: The invention relates to novel nucleic acid fragments encoding polypeptides which are capable of mediating contact between enamel and cell surface. The invention also relates to expression vectors containing the nucleic acid fragments according to the invention for production of the protein, organisms containing said expression vector, methods for producing the polypeptide, compositions comprising the polypeptides, antibodies or antibody fragments recognizing the polypeptides, and methods for treating various hard tissue diseases or disorders.

Abstract: The invention relates to novel nucleic acid fragments encoding polypeptides which are capable of mediating contact between enamel and cell surface. The invention also relates to expression vectors containing the nucleic acid fragments according to the invention for production of the protein, organisms containing said expression vector, methods for producing the polypeptide, compositions comprising the polypeptides, antibodies or antibody fragments recognizing the polypeptides, and methods for treating various hard tissue diseases or disorders.

Abstract: The invention relates to novel nucleic acid fragments encoding polypeptides which are capable of mediating contact between enamel and cell surface. The invention also relates to expression vectors containing the nucleic acid fragments according to the invention for production of the protein, organisms containing said expression vector, methods for producing the polypeptide, compositions comprising the polypeptides, antibodies or antibody fragments recognizing the polypeptides, and methods for treating various hard tissue diseases or disorders.